| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7451 |
| Human Intestinal Absorption | HIA+ | 0.9971 |
| Caco-2 Permeability | Caco2+ | 0.9199 |
| P-glycoprotein Substrate | Non-substrate | 0.6264 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7625 |
| Non-inhibitor | 0.8157 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8949 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8861 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7572 |
| CYP450 2D6 Substrate | Non-substrate | 0.8288 |
| CYP450 3A4 Substrate | Non-substrate | 0.5905 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5704 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9550 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9267 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6309 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8021 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6804 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9675 |
| Non-inhibitor | 0.9396 |
| AMES Toxicity | Non AMES toxic | 0.8820 |
| Carcinogens | Non-carcinogens | 0.8599 |
| Fish Toxicity | High FHMT | 0.8808 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9784 |
| Honey Bee Toxicity | High HBT | 0.8193 |
| Biodegradation | Not ready biodegradable | 0.5324 |
| Acute Oral Toxicity | III | 0.8684 |
| Carcinogenicity (Three-class) | Non-required | 0.5972 |